FDI equity inflow into pharma sector registers growth of 45% in FY 23 to cross $2 billion mark

The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical industry has registered a growth of 45.4 per cent in the fiscal year ended March, 2023, as compared to the…

  • News
  • September 15, 2016
Himachal Pradesh A hub for spurious drugs

 Shimla With over 600 pharmaceutical industries, the state has become medicinal hub of India as it caters to around 40% domestic demand. But due to constantly failing the quality tests…